Flower, B., Brown, J. C., Simmons, B., Moshe, M., Frise, R., Penn, R., Kugathasan, R., Petersen, C., Daunt, A., Ashby, D., Riley, S., Atchison, C. J., Taylor, G. P., Satkunarajah, S., Naar, L., Klaber, R., Badhan, A., Rosadas, C., Khan, M., Fernandez, N., Sureda-Vives, M., Cheeseman, H. M., O'Hara, J., Fontana, G., Pallett, S. J. C., Rayment, M., Jones, R., Moore, L. S. P., McClure, M. O., Cherepanov, P., Tedder, R., Ashrafian, H., Shattock, R., Ward, H., Darzi, A., Elliot, P., Barclay, W. S., & Cooke, G. S. (2020). clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. Thorax, 75(12), 1082–1088. http://access.bl.uk/ark:/81055/vdc_100150405059.0x000048